141 related articles for article (PubMed ID: 8251654)
1. Epidermal growth factor receptor levels increase but epidermal growth factor receptor ligand levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence.
Kienhuis CB; Sluyser M; de Goeij CC; Koenders PG; Benraad TJ
Breast Cancer Res Treat; 1993; 26(3):289-95. PubMed ID: 8251654
[TBL] [Abstract][Full Text] [Related]
2. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors.
Moncharmont B; Ramp G; De Goeij CC; Sluyser M
Cancer Res; 1991 Aug; 51(15):3843-8. PubMed ID: 1855202
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors.
Migliaccio A; Pagano M; De Goeij CC; Di Domenico M; Castoria G; Sluyser M; Auricchio F
Int J Cancer; 1992 Jul; 51(5):733-9. PubMed ID: 1612782
[TBL] [Abstract][Full Text] [Related]
4. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
Viegas MH; Salatino M; Goin M; Peters G; Labriola L; Costa da cunha J; Lanari C; Charreau EH; Elizalde PV
Cancer Detect Prev; 1999; 23(5):375-86. PubMed ID: 10468889
[TBL] [Abstract][Full Text] [Related]
6. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
7. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
[TBL] [Abstract][Full Text] [Related]
8. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
[TBL] [Abstract][Full Text] [Related]
9. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
Briand P
Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
[TBL] [Abstract][Full Text] [Related]
10. Hormone dependence in premalignant mammary progression.
Medina D; Kittrell FS; Shepard A; Contreras A; Rosen JM; Lydon J
Cancer Res; 2003 Mar; 63(5):1067-72. PubMed ID: 12615724
[TBL] [Abstract][Full Text] [Related]
11. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
Pewnim T; Adams JB; Ho KP
Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism and enzyme activities in hormone-dependent and hormone-independent mammary adenocarcinoma in GR mice.
Abraham S; Briand P; Hansen FN
J Natl Cancer Inst; 1986 Jul; 77(1):233-9. PubMed ID: 3088311
[TBL] [Abstract][Full Text] [Related]
14. Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants.
Buggiano V; Levy CS; Gattelli A; Cirio MC; Marfil M; Nepomnaschy I; Piazzon I; Helguero L; Vanzulli S; Kordon EC
Breast Cancer Res Treat; 2002 Oct; 75(3):191-202. PubMed ID: 12353808
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
[TBL] [Abstract][Full Text] [Related]
16. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.
Lanari C; Lamb CA; Fabris VT; Helguero LA; Soldati R; Bottino MC; Giulianelli S; Cerliani JP; Wargon V; Molinolo A
Endocr Relat Cancer; 2009 Jun; 16(2):333-50. PubMed ID: 19190078
[TBL] [Abstract][Full Text] [Related]
17. Hormone dependency of rat mammary carcinoma--a comparison of two assay systems.
Sarkar S; Seshadri R; Shah PN; Kothari LS; Ghosh SN
Neoplasma; 1979; 26(4):477-82. PubMed ID: 118387
[TBL] [Abstract][Full Text] [Related]
18. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.
Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y
Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
Giulianelli S; Cerliani JP; Lamb CA; Fabris VT; Bottino MC; Gorostiaga MA; Novaro V; Góngora A; Baldi A; Molinolo A; Lanari C
Int J Cancer; 2008 Dec; 123(11):2518-31. PubMed ID: 18767044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
